作者:Klaus Rehse、Joscha Kotthaus、Laleh Khadembashi
DOI:10.1002/ardp.200800181
日期:2009.1
Nine title compounds were synthesized and investigated in the Born test for their antiplatelet activities against collagen, ADP, adrenaline, and platelet activating factor (PAF) as inducers of the aggregation. Using collagen three compounds with IC50 values below 100 μM were found (3b, 3e, 3i). Activities in nanomolar concentrations were observed against ADP (3b, IC50 = 9.4 nM), adrenaline (3i, IC50
合成了九种标题化合物,并在 Born 试验中研究了它们对作为聚集诱导剂的胶原蛋白、ADP、肾上腺素和血小板活化因子 (PAF) 的抗血小板活性。使用胶原蛋白发现了 IC50 值低于 100 μM 的三种化合物(3b、3e、3i)。观察到纳摩尔浓度的活性对 ADP (3b, IC50 = 9.4 nM)、肾上腺素 (3i, IC50 = 5.8 nM) 和血小板激活因子 (3e, IC50 = 0.45 nM)。